SHP Wealth Management’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.67K Hold
30
– – ﹤0.01% 1449
2026
Q2
$1.67K Buy
30
+21
+233% +$1.09K ﹤0.01% 1448
2026
Q1
$439 Hold
9
– – ﹤0.01% 1644
2025
Q4
$352 Buy
+9
New +$343 ﹤0.01% 1403

Other funds holding RPRX

SHP Wealth Management's RPRX Position: Q3 2026 in Review

SHP Wealth Management held its Royalty Pharma (RPRX) position steady in Q3 2026 at 30 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #1449.

SHP Wealth Management first reported a position in RPRX in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.67K in Q2 2026. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • SHP Wealth Management held 30 shares of Royalty Pharma worth $1.67K as of Q3 2026.
  • SHP Wealth Management left its Royalty Pharma share count unchanged in Q3 2026.
  • Royalty Pharma made up ﹤0.01% of SHP Wealth Management's portfolio in Q3 2026, its #1449 holding.
  • SHP Wealth Management first reported a position in Royalty Pharma in Q4 2025 and has held it in 4 quarters since.
  • SHP Wealth Management's Royalty Pharma position peaked at $1.67K in Q2 2026.
  • 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on SHP Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.